We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
ADAMAS now part of the growth and onward direction here. Excellent addition.
Yes it hasn't performed how I had anticipated. Generally the larger trades seem to be buying and numerous smaller trades selling. This is a longterm investment for myself and Im very happy with the books being filled and the future of this expanding company. RNS was very good.
I will be adding again shortly hopefully when I get some successful outcomes elsewhere. Happily I will be paying a lot less than perhaps I could have.
You really put a hex on it there Sheephatch!
What's happened? A very positive RNS and yet it drops over 25%.
Has anyone figured it out?
Great start to the New Year.
Things looking very strong.
Just a quick look at careers on the company website shows how they are expanding and pushing forward.
The appointment of Zizi Uzezi looks very exciting with her terrific background and brings a huge amount to experience to Ergo.
SP will continue to move up gradually in my opinion and then we could see significant jumps on updates.
Personally I will be adding at every opportunity as and when the opportunity arises.
I think I have the answer. Nearly 3 hours' trading today and only one trade, for 790 shares. Hopefully it's down to the time of year.
The bid/offer spread is 6.71% at the moment, which is a deterrent to buyers. Is it this wide usually? Maybe it is due to low volume?
Todays performance should hopefully put us on a few peoples radars. Lets hope this strong buying continues well into the New Year. Another set of strong results will see this heading well above previous highs.
CINE was one certainly to get out of. Just in time.
Yes Ergomed has had a cracking run over recent years and has matured into a solid business with a fat order book in the safe hands of Richard Barfield.
Purchased my 2 x 250 trades this morning. Hopefully we will be looking at a continual rise from here. We know the order books are bulging and a similar growth like the previous 12 months would be very nice. I have a lot of confidence in this company and we could even see better results then expected.
Govt possibly about to announce Plan B. ERGO offering a safe place to invest. Im moving in more funds here tomorrow after update over at RR. CINE and TUI etc, etc all in trouble for a few months.
Some decent buying returning now. The company has very exciting plans ahead and deep pockets which will enable a number of further acquisitions shortly. Share price returning to its onwards trajectory and an time high not too far down the road.
Another strong set of results -
- Total revenue growth of 38.8% over H1 2020 to £56.0 million (up 48.1% in constant currency*)
- adjusted EBITDA of £12.1 million up 33.0%
- Net new sales awards in H1 2021 increased by 50.8% over H1 2020
- Cash balance increased to £24.6 million and debt free
Ergomed has been shortlisted in the AIM Growth Business of the Year and also Company of the Year Award catagories.
https://www.aim-awards.co.uk/nominations-overview/
Ergomed are presenting at a Proactive One2One on 21st October:-
https://www.proactiveinvestors.co.uk/register/event_details/363
The share price movement in recent weeks had been confusing me and maybe today's RNS explains this. Hopefully the share price will now stabilize.
Courtesy of Piedro on advfn
https://www.edisongroup.com/wp-content/uploads/2021/08/Ergomed-Momentum-continues-with-EBITDA-upgrades-1.pdf
In case you missed our webinar with Ergomed the recording and stockopedia report can be found here: https://www.sharesoc.org/seminar/sharesoc-webinar-with-ergomed-plc-ergo-29-july-2021/
To access the recording, you'll need to be a full member of ShareSoc, which is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. If you're not already a member you can join here: hxxps://www.sharesoc.org/membership/
Once you've joined, you'll receive an invitation to register for our "members network" private social network, from where you'll be able to access the recording (and recordings/reports on 100s of other meetings). If you're already a member and have any difficulty accessing the report, please do not hesitate to contact us here: hxxps://www.sharesoc.org/contact-us/
Agreed. Excellent company. Share price slightly down this morning. Doubled my holding. Long term looks good to me.
Another strong trading update today from Ergomed. Good to see new acquisitions contributing as expected, but also to see organic growth as well as acquisitive growth.
https://www.proactiveinvestors.co.uk/companies/news/956036/ergomed-deliver-double-digit-revenue-growth-as-well-as-operational-progress-956036.html
Last chance to register for our webinar with Ergomed on the 29th July. Richard Barfield (CFO) will be presenting the latest updates which may be of interest to current shareholders and potential investors. https://www.sharesoc.org/events/sharesoc-webinar-with-ergomed-plc-ergo29-july-2021/
We are hosting a webinar with Ergomed plc on the 29th July which may be of interest to current shareholders and potential investors: https://www.sharesoc.org/events/sharesoc-webinar-with-ergomed-plc-ergo29-july-2021/
Shocking 7.26% spread
But the spread has opened up which suggests there are not enough free shares in the market, so something for the board to consider or the MMs.